Quarterly Results

DECCAN HEALTH CARE LTD.

NSE : NABSE : 542248ISIN CODE : INE452W01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE25.08-0.16 (-0.63 %)
PREV CLOSE ( ) 25.24
OPEN PRICE ( ) 25.24
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 73240
TODAY'S LOW / HIGH ( )24.86 25.28
52 WK LOW / HIGH ( ) 23.142
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Dec 2022
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
153.43
171.79
112.38
86.46
Total Expenditure
141.21
161.37
104.3
88.52
PBIDT (Excl OI)
12.22
10.42
8.08
-2.06
Other Income
0.00
0.01
0.06
0.1
Operating Profit
12.22
10.43
8.14
-1.95
Interest
0.36
0.03
0.21
0.36
Exceptional Items
NA
NA
NA
NA
PBDT
11.86
10.4
7.93
-2.31
Depreciation
4
3.16
3.93
3.56
Profit Before Tax
7.86
7.24
4
-5.87
Tax
2.61
1.82
1.01
-1.26
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
5.25
5.42
2.99
-4.61
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
5.25
5.42
2.99
-4.61
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
5.25
5.4
2.99
-4.62
Equity Capital
203.76
170.43
170.43
170.43
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
0.25
0.31
0.17
-0.27
Calculated EPS (Annualised)
1.03
1.26
0.70
-1.08
No of Public Share Holdings
17091166
13758166
13758166
NA
% of Public Share Holdings
83.88
80.73
80.73
NA
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
7.96
6.06
7.18
-2.38
PBIDTM%
7.96
6.07
7.24
-2.26
PBDTM%
7.72
6.05
7.05
-2.68
PBTM%
5.12
4.21
3.55
-6.80
PATM%
3.42
3.15
2.66
-5.34
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.